Ridgepost Capital, Inc. annual report, FY2021

Business context and reporting period

The supplied filing is P10, Inc.’s audited Form 10-K for the fiscal year ended December 31, 2021—not a standalone fourth-quarter report. The request metadata names Ridgepost Capital, Inc., which does not match the registrant identified in the filing; verify the intended company and filing. P10 is a private-markets asset manager spanning private equity, venture capital, impact investing and private credit. Its revenue is primarily recurring management and advisory fees. The company completed its IPO in October 2021 and acquired Hark and Bonaccord on September 30, 2021.

Financial and operating highlights

• Management and advisory fees were $149.4 million, up 126%; the filing cites acquisitions and increased fundraising/FPAUM. Average fee rates were approximately 1%.
• Operating expenses rose 88% to $110.2 million, including $30.4 million of intangible amortization and $54.8 million of compensation and benefits.
• Interest expense and debt-extinguishment loss contributed to total other expense of $36.6 million. The $15.3 million extinguishment loss included cash and noncash items. The reported $7.1 million tax benefit helped lift net income; the prior-year benefit was $26.8 million.
• Non-GAAP Adjusted EBITDA was $83.1 million and Adjusted Net Income was $62.8 million. These are management-defined measures and should be considered alongside GAAP results.
• Year-end cash, cash equivalents and restricted cash totaled $43.5 million. The company reported $34.1 million of remaining availability under its revolving facility.
• Cash used in investing was $47.4 million, mainly for Hark and Bonaccord acquisitions; cash provided by financing was $29.1 million, reflecting IPO proceeds and refinancing-related borrowing and repayments.

Material changes versus prior period

• Revenue more than doubled, primarily because 2020 acquisitions were included for fuller periods in 2021 and FPAUM grew. Reported comparisons are affected by acquisition timing and are not like-for-like.
• FPAUM increased 35.9% on an actual basis to $17.3 billion; pro forma growth was 29.3%. Capital raised was $3.4 billion actual, while scheduled fee-base stepdowns reduced FPAUM by $427 million.
• Operating income improved, but net income declined from $23.8 million to $10.8 million, mainly reflecting higher interest and the debt-extinguishment charge and a substantially smaller income-tax benefit.
• The October IPO generated approximately $129.4 million of net proceeds to the company before expenses. The company also completed a December refinancing: a $125 million term loan and $125 million revolving facility, with $125 million and $90.9 million drawn, respectively, at year-end. The new facility bears interest at SOFR plus the applicable spread and matures December 22, 2025.
• In February 2022, P10 repaid $25 million of the revolver. The filing states expected 2022 interest expense of $7.3 million under the new financing, versus $20.9 million incurred in 2021 on the previous debt arrangements; these figures are not directly comparable.

Outlook, risks and unusual items

Management expects growth through fundraising, cross-selling, new solutions and selective acquisitions, but gives no specific financial guidance. It cites a 7.2-year weighted-average remaining duration of capital under management and approximately $726 million of committed, undeployed AUM not yet included in FPAUM. Management said COVID-19 had not materially harmed the business and near-term impact was not expected to be significant given contract structures, while acknowledging possible fundraising and deployment delays.

• Key exposures include fundraising and investor retention, investment performance, competition for managers and deals, talent retention, subjective private-asset valuations, illiquidity, conflicts of interest and regulatory change.
• Rising rates or tighter credit could affect debt costs, portfolio companies and investor allocations. A 100-basis-point rate increase was estimated to raise annual interest expense by approximately $2.3 million on year-end borrowings.
• Acquisition-related contingent consideration was $23.0 million at year-end, measured using Level 3 inputs; the ultimate payments may differ from estimates. The Enhanced advisory-fee arrangement depends on the future cash flows of Enhanced PC; $19 million of related fees was recognized in 2021.
• The company reported $220.4 million of federal NOL carryforwards, subject to expiration and potential Section 382 ownership-change limits. NOL utilization and tax benefits are uncertain.
• Class B shares carried ten votes per share before a specified Sunset, giving holders approximately 95% of combined voting power initially after the IPO as described in the filing; the dual-class structure and controlled-company status limit Class A holders’ influence.
• KPMG issued an unqualified opinion on the financial statements. Management concluded disclosure controls were effective; the company was an emerging growth company and did not report an auditor attestation under Section 404(b).
• No material legal proceedings were reported. The company does not currently pay dividends and does not anticipate doing so in the foreseeable future.

Important facts for investors to verify

• Confirm whether P10, Inc. is the intended issuer, given the Ridgepost Capital metadata mismatch.
• Reconcile the year-end debt figures: the balance sheet reports $212.5 million net of issuance costs, while facility principal was $215.9 million gross.
• Assess the sustainability of FPAUM and fee growth against scheduled fee stepdowns, fundraising cycles and the contribution from acquisitions.
• Review the refinancing terms, covenant headroom, revolver repayment after year-end and management’s interest-expense estimate.
• Evaluate the tax benefit, NOL expiration and ownership-change limitations, along with contingent consideration and Enhanced PC fee collectability.
• Distinguish reported GAAP earnings and cash flows from Adjusted EBITDA and Adjusted Net Income, and account for the IPO-related share-count increase and dilution.